Genetic tests for common diseases: new insights, old concerns
- 13 March 2008
- Vol. 336 (7644) , 590-593
- https://doi.org/10.1136/bmj.39506.601053.be
Abstract
The clinical utility of newly identified genetic variants associated with common diseases needs evaluation Genome-wide studies have recently identified many new variants associated with common diseases. Findings point mainly to sets of variants with modest effects, with many more markers still to be discovered. Some variants are shedding new light on disease mechanisms and on previously unsuspected parts of the genome. Much more work is needed, however, to define the clinical relevance and value to patients of testing for these new genetic markers. It is worrying that in the absence of this knowledge, commercial genetic testing services are being marketed directly to the public. In this paper we describe key findings from the new genome-wide association studies; draw attention to the currently weak regulatory systems, particularly in Europe; and argue the case for improved evaluation, greater transparency, and better regulation, so that the new genetic tests can be used in a safe and informed way. Environmental factors are major contributors to the development of most common diseases. However, conditions including myocardial infarction, type 2 diabetes, asthma, and even the ageing process itself are influenced by inherited variations in DNA sequence.1 The most common DNA variant is the substitution of a single base pair: when these occur at a population prevalence of 1% or more; they are termed single nucleotide polymorphisms or SNPs (pronounced “snips”). More complex variants exist, including deletions, insertions, and copy number variations, but most of the recent work on the genetics of common diseases has focused on SNPs. In tandem with the sequencing of the human genome, extraordinary advances have occurred in the technology for determining the status of SNPs. The original wet laboratory techniques gave way to robotic systems and then to miniaturisation. The latest format has test probes arrayed on the surface of a …Keywords
This publication has 19 references indexed in Scilit:
- A second generation human haplotype map of over 3.1 million SNPsNature, 2007
- A new era for Type 2 diabetes geneticsDiabetic Medicine, 2007
- Advert for breast cancer gene test triggers inquiryBMJ, 2007
- Cancer, heart, and diabetes societies join to publicise uninsured AmericansBMJ, 2007
- The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studiesDiabetic Medicine, 2007
- The common biology of cancer and ageingNature, 2007
- A common variant of the p16INK4a genetic region is associated with physical function in older peopleMechanisms of Ageing and Development, 2007
- Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease PredictionPLoS Medicine, 2006
- Genetic Testing Has No Place as a Routine Diagnostic Test in Sporadic and Familial Cases of Alzheimer's DiseaseJournal of the American Geriatrics Society, 2004
- The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease associationHuman Mutation, 2004